Recent Updates
Recently added Catalysts
SNDL

Sundial Growers Inc. Condensed Consolidated Interim Financial Statements For the three and six months ended

Key Takeaway: Sundial Growers Inc. Condensed Consolidated Interim Financial Statements For the three and six months ended June 30, 2021 (Unaudited - expressed in thousands of Canadian dollars) Sundial Growers Inc. Condensed Consolidated Interim Statement of Financial Position (Unaudited

Full Press Release Details

Sundial Growers Inc.
Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2021
(Unaudited - expressed in thousands of Canadian dollars)
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Financial Position
(Unaudited - expressed in thousands of Canadian dollars)
As at Note June 30, 2021 December 31, 2020 (1)
Assets
Current Assets
Cash and cash equivalents 885,418 60,376
Restricted cash 6 52,449 5,333
Marketable securities 7 97,419 -
Accounts receivable 8 8,853 15,898
Biological assets 9 2,341 3,531
Inventory 10 35,194 25,613
Prepaid expenses and deposits 3,202 4,622
Investments 13 3,049 -
Assets held for sale 2,998 2,998
1,090,923 118,371
Non-current assets
Long-term deposits 7,981 2,633
Property, plant and equipment 11 53,409 116,928
Intangible assets 12 4,886 5,063
Investments 13 62,480 51,876
Equity-accounted investees 14 191,599 -
Total assets 1,411,278 294,871
Liabilities
Current liabilities
Accounts payable and accrued liabilities 24,559 23,308
Current portion of lease obligations 415 409
Derivative warrants 15 54,000 428
78,974 24,145
Non-current liabilities
Lease obligations 804 1,031
Total liabilities 79,778 25,176
Shareholders' equity
Share capital 16(b) 2,003,013 762,046
Warrants 16(c) 6,138 6,138
Contributed surplus 64,901 59,344
Contingent consideration 2,279 2,279
Accumulated deficit (1) (744,831 ) (558,128 )
Total shareholders' equity 1,331,500 271,679
Non-controlling interest (1) - (1,984 )
Total liabilities and shareholders' equity 1,411,278 294,871
Commitments (note 26)
Subsequent events (note 27)
See accompanying notes to the condensed consolidated interim financial statements.
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Loss and Comprehensive Loss
(Unaudited - expressed in thousands of Canadian dollars, except per share amounts)
Three months ended June 30 Six months ended June 30
Note 2021 2020 2021 2020
Gross revenue 18 12,739 24,341 24,487 40,931
Excise taxes 3,588 4,147 5,445 6,731
Net revenue 9,151 20,194 19,042 34,200
Cost of sales 10 9,534 17,336 20,979 30,843
Inventory obsolescence 10 1,651 10,026 3,405 17,741
Gross margin before fair value adjustments (2,034 ) (7,168 ) (5,342 ) (14,384 )
Change in fair value of biological assets 9 (331 ) (1,756 ) (425 ) 4,659
Change in fair value realized through inventory 10 (456 ) (6,213 ) (506 ) (15,905 )
Gross margin (2,821 ) (15,137 ) (6,273 ) (25,630 )
Interest and fee revenue 19 3,344 - 6,193 -
Investment revenue 19 2,362 - 15,262 -
Share of profit of equity-accounted investees 14 3,724 - 3,724 -
General and administrative 10,086 7,735 17,179 18,343
Sales and marketing 1,315 518 2,265 2,310
Research and development 758 36 993 343
Depreciation and amortization 11,12 931 1,277 1,989 1,934
Share-based compensation 17 4,539 3,152 7,995 3,947
Restructuring costs - 2,363 - 5,082
Asset impairment 11 60,000 - 60,000 5,659
Government subsidies 20 - - (2,180 ) -
Income (loss) from operations (71,020 ) (30,218 ) (69,335 ) (63,248 )
Transaction costs (805 ) (1,297 ) (4,453 ) (2,398 )
Finance costs 21 (40 ) (1,002 ) (91 ) (6,984 )
Change in estimate of fair value of derivative warrants 15 19,810 411 (110,134 ) 411
Foreign exchange gain (loss) (208 ) (599 ) (648 ) 955
Gain (loss) on disposition of PP&E (22 ) (122 ) (139 ) 488
Other expenses 14(b) (2 ) - (1,932 ) -
Loss before income tax (52,287 ) (32,827 ) (186,732 ) (70,776 )
Net loss from continuing operations (52,287 ) (32,827 ) (186,732 ) (70,776 )
Net loss from discontinued operations 4 - (27,593 ) - (33,627 )
Net loss (52,287 ) (60,420 ) (186,732 ) (104,403 )
Gain on translation of foreign operations - (1,093 ) - 600
Comprehensive loss (52,287 ) (61,513 ) (186,732 ) (103,803 )
Net loss from continuing operations attributable to:
Sundial Growers Inc. (52,287 ) (32,750 ) (186,703 ) (70,611 )
Non-controlling interest - (77 ) (29 ) (165 )
(52,287 ) (32,827 ) (186,732 ) (70,776 )
Net loss attributable to:
Sundial Growers Inc. (52,287 ) (60,343 ) (186,703 ) (104,238 )
Non-controlling interest - (77 ) (29 ) (165 )
(52,287 ) (60,420 ) (186,732 ) (104,403 )
Comprehensive loss attributable to:
Sundial Growers Inc. (52,287 ) (61,436 ) (186,703 ) (103,638 )
Non-controlling interest - (77 ) (29 ) (165 )
(52,287 ) (61,513 ) (186,732 ) (103,803 )
Net loss per common share attributable to Sundial Growers Inc.
Basic and diluted 22 $ (0.03 ) $ (0.57 ) $ (0.11 ) $ (0.97 )
See accompanying notes to the condensed consolidated interim financial statements.
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Changes in Shareholders' Equity
(Unaudited - expressed in thousands of Canadian dollars)
Note Share capital Warrants Contributed surplus Contingent consideration Accumulated deficit (1) Accumulated other comprehensive income Non- controlling interest (1) Total equity
Balance at December 31, 2020 (1) 762,046 6,138 59,344 2,279 (558,128 ) - (1,984 ) 269,695
Net loss - - - - (186,703 ) - (29 ) (186,732 )
Loss of control of subsidiary 14(b) - - - - - - 2,013 2,013
Share issuances 16(b) 977,425 - - - - - - 977,425
Share issuance costs 16(b) (16,233 ) - - - - - - (16,233 )
Derivative warrants exercised 15 277,136 - - - - - - 277,136
Share-based compensation 17 6 - 7,989 - - - - 7,995
Employee awards exercised 2,633 - (2,432 ) - - - - 201
Balance at June 30, 2021 2,003,013 6,138 64,901 2,279 (744,831 ) - - 1,331,500
Balance at March 31, 2021 1,675,595 6,138 60,370 2,279 (692,544 ) - - 1,051,838
Net loss - - - - (52,287 ) - - (52,287 )
Share issuances 16(b) 330,110 - - - - - - 330,110
Share issuance costs 16(b) (2,750 ) - - - - - - (2,750 )
Share-based compensation 17 5 - 4,534 - - - - 4,539
Employee awards exercised 53 - (3 ) - - - - 50
Balance at June 30, 2021 2,003,013 6,138 64,901 2,279 (744,831 ) - - 1,331,500
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Changes in Shareholders' Equity
(Unaudited - expressed in thousands of Canadian dollars)
Note Share capital Warrants Contributed surplus Contingent consideration Accumulated deficit Accumulated other comprehensive income Non- controlling interest Total equity
Balance at December 31, 2019 509,654 27,831 30,192 2,279 (360,338 ) 6,866 4,714 221,198
Net loss - - - - (104,238 ) - (165 ) (104,403 )
Other comprehensive income - - - - - 600 - 600
Share issuances 610 - - - - - - 610
Dispositions 4 (38,447 ) - - - 35,456 (7,466 ) - (10,457 )
Share-based compensation 17 51 - 3,070 - - - - 3,121
Balance at June 30, 2020 471,868 27,831 33,262 2,279 (429,120 ) - 4,549 110,669
Balance at March 31, 2020 510,314 27,831 31,378 2,279 (404,233 ) 8,559 4,626 180,754
Net loss - - - - (60,343 ) - (77 ) (60,420 )
Other comprehensive loss - - - - - (1,093 ) - (1,093 )
Dispositions 4 (38,447 ) - - - 35,456 (7,466 ) - (10,457 )
Share-based compensation 17 1 - 1,884 - - - - 1,885
Balance at June 30, 2020 471,868 27,831 33,262 2,279 (429,120 ) - 4,549 110,669
See accompanying notes to the condensed consolidated interim financial statements.
Sundial Growers Inc.
Condensed Consolidated Interim Statement of Cash Flows
(Unaudited - expressed in thousands of Canadian dollars)
Three months ended June 30 Six months ended June 30
Note 2021 2020 2021 2020
Cash provided by (used in):
Operating activities
Net loss from continuing operations for the period (52,287 ) (32,827 ) (186,732 ) (70,776 )
Items not involving cash:
Change in fair value of biological assets 331 1,756 425 (4,659 )
Share-based compensation 17 4,539 3,152 7,995 3,947
Depreciation and amortization 11,12 2,364 2,946 4,771 5,869
(Gain) loss on disposition of PP&E 22 122 139 (488 )
Inventory obsolescence 10 1,651 10,026 3,405 17,741
Finance costs 21 29 (100 ) 52 1,816
Change in estimate of fair value of derivative warrants 15 (19,810 ) (411 ) 110,134 (411 )
Unrealized foreign exchange (gain) loss 104 583 2,009 (1,186 )
Restructuring costs - 448 - 448
Asset impairment 11 60,000 - 60,000 5,659
Share of profit of equity-accounted investees 14(a) (3,724 ) - (3,724 ) -
Other expenses 14(b) 2 - 1,864 -
Gain on disposition of marketable securities 7,19 (4,211 ) - (12,230 ) -
Unrealized (gain) loss on marketable securities 7 1,849 - (3,032 ) -
Additions to marketable securities 7 (69,593 ) - (106,333 ) -
Proceeds from disposal of marketable securities 7 8,118 - 24,176 -
Change in non-cash working capital 234 1,799 (7,667 ) 12,024
Net cash used in operating activities from continuing operations (70,382 ) (12,506 ) (104,748 ) (30,016 )
Net cash provided by operating activities from discontinued operations 4 - 756 - 4,820
Net cash used in operating activities (70,382 ) (11,750 ) (104,748 ) (25,196 )
Investing activities
Additions to property, plant and equipment 11 (1,745 ) (117 ) (1,864 ) (1,793 )
Additions to investments 13 (3,000 ) - (13,560 ) -
Additions to equity-accounted investees 14(b) (187,875 ) - (187,875 ) -
Proceeds from disposal of PP&E 11 55 3 115 2,103
Change in non-cash working capital 277 (2,629 ) 37 (10,690 )
Net cash used in investing activities from continuing operations (192,288 ) (2,743 ) (203,147 ) (10,380 )
Net cash used in investing activities from discontinued operations 4 - (1,671 ) - (6,617 )
Net cash used in investing activities (192,288 ) (4,414 ) (203,147 ) (16,997 )
Financing activities
Proceeds from convertible notes, net of costs - 18,629 - 18,629
Change in restricted cash 6 (52,349 ) 2 (47,116 ) 10,497
Repayment of Syndicated Credit Agreement - (662 ) - (10,662 )
Payments on lease obligations (122 ) (100 ) (245 ) (219 )
Proceeds from issuance of shares and registered offerings, net of costs 16(b) 327,360 - 1,062,448 -
Proceeds from exercise of derivative warrants 15 - - 119,318 -
Proceeds from exercise of employee warrants 17 50 - 201 -
Change in non-cash working capital (197 ) (436 ) 382 (643 )
Net cash provided by financing activities from continuing operations 274,742 17,433 1,134,988 17,602
Net cash used in financing activities from discontinued operations 4 - (761 ) - (639 )
Net cash provided by financing activities 274,742 16,672 1,134,988 16,963
Effect of exchange rate changes on cash held in foreign currency (99 ) (36 ) (2,051 ) 1,522
Change in cash and cash equivalents 11,973 472 825,042 (23,708 )
Cash and cash equivalents, beginning of period 873,445 21,157 60,376 45,337
Cash and cash equivalents, end of period 885,418 21,629 885,418 21,629
Cash interest paid - 2,655 - 3,850
See accompanying notes to the condensed consolidated interim financial statements.
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
Sundial Growers Inc. ("Sundial" or the "Company") was incorporated under the Business Corporations Act (Alberta) on August 19, 2006.
The Company's head office is located at 300, 919 11th Avenue SW, Calgary, Alberta, Canada.
The principal activities of the Company are the production, distribution and sale of cannabis in Canada pursuant to the Cannabis Act and the deployment of capital to investment opportunities. The Cannabis Act regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada.
Sundial and its subsidiaries currently operate solely in Canada. Through its joint venture SunStream Bancorp Inc. (note 14(a)), the Company also provides growth capital and a strategic support platform that pursues indirect investment opportunities in the global cannabis sector, where lawful, as well as other investment opportunities. The Company also makes portfolio investments in debt and equity securities where deemed strategic.
The Company's common shares trade on the Nasdaq Capital Market ("Nasdaq") under the ticker symbol "SNDL".
The global impact of COVID-19 has contributed to a great deal of uncertainty as to the health of the global economy. The Company has implemented several new pandemic-related procedures and protocols at its facilities, including enhanced screening measures, enhanced cleaning and sanitation processes and frequency, encouraging social distancing measures and directing employees to work from home if possible. The Company believes that it can maintain safe operations with these pandemic-related procedures and protocols in place.
COVID-19 has not had a material impact on the Company's business to date, however, any potential future impact that COVID-19 could have on the Company's business or financial results cannot be reasonably estimated at this time. However, any shutdowns requested or mandated by government authorities in response to the outbreak of COVID-19 that may affect the Company, its suppliers, distribution channels or customers may have a material impact to the Company's planned operations.
The condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard 34 - Interim Financial Reporting as issued by the International Accounting Standards Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"). The condensed consolidated interim financial statements were prepared using the same accounting policies and methods as those disclosed in the audited consolidated financial statements for the year ended December 31, 2020, except as described in note 3. The condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements for the Company for the year ended December 31, 2020 which have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the IASB.
These condensed consolidated interim financial statements were approved and authorized for issue by the Board of Directors ("Board") on August 12, 2021.
These condensed consolidated interim financial statements have been prepared on a historical cost basis, except for biological assets and certain financial instruments (note 23(a)) which are measured at fair value with changes in fair value recorded in earnings.
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
These condensed consolidated interim financial statements are presented in Canadian dollars, which is the functional and presentation currency of the Company and its Canadian based subsidiaries.
Subsidiaries are entities controlled by the Company. Control exists when the Company has the power, directly and indirectly, to govern the financial and operating policies of an entity and be exposed to the variable returns from its activities. The financial statements of subsidiaries are included in these condensed consolidated interim financial statements from the date that control commences until the date that control ceases.
Subsidiaries Jurisdiction of incorporation Percentage ownership
Sprout Technologies Inc. Alberta, Canada 100 %
KamCan Products Inc. British Columbia, Canada 100 %
2011296 Alberta Inc. Alberta, Canada 100 %
Sundial Deutschland GmbH Germany 100 %
Sundial Portugal, Unipessoal LDA Portugal 100 %
2657408 Ontario Inc. Ontario, Canada 100 %
NGBA-BC Holdings Ltd. British Columbia, Canada 100 %
Sundial Insurance (Bermuda) Ltd. Bermuda 100 %
The accounting policies, critical accounting judgements and significant estimates used in the preparation of the Company's audited consolidated financial statements for the year ended December 31, 2020 have been applied in the preparation of these condensed consolidated interim financial statements except as described below.
When the Company loses control over a subsidiary, it derecognizes the assets and liabilities of the subsidiary, and any related non-controlling interest and other components of equity. Any resulting gain or loss is recognized in profit or loss. Any interest retained in the former subsidiary is measured at fair value when control is lost.
Interests in equity-accounted investees
The Company's interest in equity-accounted investees comprise interests in an associate and a joint venture.
Associates are those entities in which the Company has significant influence, but not control or joint control, over the financial and operating policies. A joint venture is an arrangement in which the Company has joint control, whereby the Company has rights to the net assets of the arrangement, rather than rights to assets and obligations for its liabilities.
Interests in associates and joint ventures are accounted for using the equity method. They are initially recognized at cost, which includes transaction costs. Subsequent to initial recognition, the consolidated financial statements include the Company's share of the profit or loss and OCI of equity-accounted investees, until the date on which significant influence or joint control ceases.
The Company has secured insurance coverage for its directors and officers through two separate captive insurance structures.
The first structure is a captive cell program entered into with a registered insurer for the purpose of holding and managing the Company's coverage funds through a separate cell account ("Cell Captive"). The Company applies IFRS
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
10 Consolidated Financial Statements in its assessment of control as it relates to the Cell Captive. The Company's accounting policy is to consolidate the Cell Captive. The Cell Captive funds are held as cash and may be invested according to the Company's treasury policy. The funds are disclosed as restricted cash as the Cell Captive must be fully funded at all times. The Company will recognize any gains or losses from fair market value adjustments, interest and/or foreign exchange in the Statement of Loss and Comprehensive Loss.
The second structure is a wholly owned subsidiary, Sundial Insurance (Bermuda) Ltd. ("SIBL"), incorporated to provide separate and additional coverage. The Company applies IFRS 10 Consolidated Financial Statements in its assessment of control as it relates to SIBL. The Company's accounting policy is to consolidate SIBL. The funds are disclosed as restricted cash as the funds were required for initial capitalization of the entity and there is a requirement to maintain minimum capital and surplus in accordance with industry regulations.
On May 15, 2020, the Company entered into an agreement to sell all of the outstanding shares of Project Seed Topco ("Bridge Farm") which closed on June 5, 2020.
The comparative statement of loss and comprehensive loss and statement of cash flows has been re-presented to show the discontinued operation separately from continuing operations.
Results of discontinued operations
Three months ended June 30 Six months ended June 30
2021 2020 (1) 2021 2020 (2)
Gross revenue - 13,108 - 22,139
Net revenue - 13,108 - 22,139
Cost of sales - 8,651 - 15,633
Gross margin before fair value adjustments - 4,457 - 6,506
Change in fair value of biological assets - 396 - 1,064
Change in fair value realized through inventory - (1,122 ) - (1,122 )
Gross margin - 3,731 - 6,448
General and administrative - 4,800 - 8,585
Sales and marketing - 930 - 1,418
Depreciation and amortization - 1,162 - 2,752
Foreign exchange - (667 ) - 1,057
Share-based compensation - (1,267 ) - (826 )
Loss from operations - (1,227 ) - (6,538 )
Finance costs - (9,891 ) - (10,083 )
Loss on contingent consideration - (1,491 ) - (2,252 )
Loss on disposition of Bridge Farm - (14,979 ) - (14,979 )
Loss before income tax - (27,588 ) - (33,852 )
Income tax recovery - (5 ) - 225
Net loss (3) - (27,593 ) - (33,627 )
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
Effect of disposal on the financial position of the company
Cash and cash equivalents 2,963
Accounts receivable 15,641
Biological assets 2,831
Inventory 787
Property, plant and equipment 88,698
Goodwill 11,345
Intangible assets 23,884
Accounts payable and accrued liabilities (22,792 )
Lease obligation (14,894 )
Deferred tax liability (3,115 )
Accumulated other comprehensive income (7,466 )
Net assets and liabilities 97,882
Consideration received
Term Debt Facility 45,000
Contingent consideration liability 34,912
Cancellation of common shares 2,991
Total consideration 82,903
Loss on disposition (14,979 )
Late in the fourth quarter of 2020 the Company began the deployment of capital toward strategic investments. The Company developed an internal capital program to evaluate these and potential future investments, which the Company viewed as a new and separate business line from its cannabis operations.
Based on the allocation of the Company's resources by the chief operating decision maker and the information used to analyze the performance of the business, the Company concluded that beginning in Q1 2021, it had two operating segments: cannabis and investments. For the three and six months ended June 30, 2020, there was only one reportable segment and therefore no comparative segment information.
The Company's reportable segments are organized by business line and are comprised of two reportable operating segments: cannabis operations and investment operations. Cannabis operations include the cultivation, distribution and sale of cannabis for the adult-use market and medical markets in Canada. Investment operations include the deployment of capital to investment opportunities. Certain overhead expenses not directly attributable to either the cannabis operations segment or investment operations segment are reported in a third segment referred to as "Corporate".
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
Cannabis Investments Corporate Total
As at June 30, 2021
Total assets 274,091 1,134,189 2,998 1,411,278
Six months ended June 30, 2021
Net revenue 19,042 21,455 - 40,497
Gross margin (6,273 ) 21,455 - 15,182
Share of profit of equity-accounted investees - 3,724 - 3,724
Depreciation and amortization 1,782 - 207 1,989
Earnings (loss) before tax (84,623 ) 23,351 (125,460 ) (186,732 )
Three months ended June 30, 2021
Net revenue 9,151 5,706 - 14,857
Gross margin (2,821 ) 5,706 - 2,885
Share of profit of equity-accounted investees - 3,724 - 3,724
Depreciation and amortization 828 - 103 931
Earnings (loss) before tax (75,451 ) 9,051 14,113 (52,287 )
As at June 30, 2021 December 31, 2020
Letters of credit - 5,333
Securities collateral 36,224 -
Captive insurance 16,225 -
52,449 5,333
Securities collateral is comprised of a cash balance to satisfy margin requirements on the Company's option trading position.
The Company has secured insurance coverage for its directors and officers through two separate captive insurance structures. The first structure is a captive cell program entered into with a registered insurer for the purpose of holding and managing the Company's coverage funds through a separate cell account ("Cell Captive"). The cell account was funded with $12.1 million and is required to be fully funded at all times. The second structure is a wholly incorporated subsidiary, Sundial Insurance (Bermuda) Ltd., which was incorporated to provide separate and additional coverage and initially funded with $4.1 million.
As at June 30, 2021 December 31, 2020
Balance, beginning of year - -
Additions 106,333 -
Dispositions (11,946 ) -
Change in fair value recognized in profit or loss 3,032 -
Balance, end of period 97,419 -
During the six months ended June 30, 2021, proceeds of $24.2 million were received for dispositions of marketable securities and a gain on disposition of $12.2 million was recognized (note 19).
Marketable securities have been designated as Fair Value Through Profit or Loss ("FVTPL") (note 23).
Sundial Growers Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the three and six months ended June 30, 2021
(Unaudited, expressed in thousands of Canadian dollars, except where otherwise noted)
The components of marketable securities are as follows:
As at June 30, 2021 December 31, 2020
Equity securities 98,703 -
Put and call options (1,284 ) -
97,419 -
As at June 30, 2021 December 31, 2020
Trade receivables 8,351 15,786
Other receivables 502 112
8,853 15,898
The Company has calculated expected credit losses ("ECLs") based on lifetime expected credit losses, taking into consideration historical credit loss experience and financial factors specific to the debtors and general economic conditions. Refer to note 23 for credit risk disclosures.
The Company's biological assets consist of cannabis plants in various stages of vegetation, including plants which have not been harvested. The change in carrying value of biological assets are as follows:
As at June 30, 2021 December 31, 2020
Balance, beginning of year 3,531 14,309
Increase in biological assets due to capitalized costs 13,373 39,957
Net change in fair value of biological assets (425 ) 6,496
Transferred to inventory upon harvest (14,138 ) (54,388 )
Disposition of Bridge Farm (note 4) - (2,831 )
Foreign currency translation - (12 )
Balance, end of period 2,341 3,531
Biological assets are valued in accordance with IAS 41 and are presented at their fair value less costs to sell up to the point of harvest. This is determined using a model which estimates the expected harvest yield in grams for plants currently being cultivated, and then adjusts that amount for the expected selling price less costs to produce and sell per gram.
Last updated: Aug 12, 2021